Moteur de recherche d’entreprises européennes
Financement de l’UE (3 998 796 €) : Éclairer de nouvelles voies en thérapie de l’insuffisance cardiaque Hor14/01/2026 Programme de recherche et d'innovation de l'UE « Horizon »
Texte
Éclairer de nouvelles voies en thérapie de l’insuffisance cardiaque
HeartVision is an ambitious high-risk, high-gain project that aims to unlock real-time, in vivo 3D microscopy of beating hearts and engineered heart tissues (EHTs) at cell-scale resolution – even deep within tissue folds. Heart failure is the leading cause of death worldwide, and today, there is no curative therapy for it. EHT transplantation offers hope, but we currently lack tools to assess its effectiveness in real time. Critical questions remain unanswered: Where do transplanted cardiomyocytes go? How do they integrate? When do they start contributing to heart function? Today, even imaging cells deep within therapy-scale EHTs is not possible - let alone in a beating heart. HeartVision will generate multiple IPs with potential in current and future clinical and biotech markets, while ensuring open access to key scientific breakthroughs. It strikes a bold balance between innovation exploitation and open science dissemination. HeartVision will realize the dream of cell-scale imaging in living organs and put it in the hands of therapy developers, reshaping how we see, study, and treat heart failure and beyond.
| Universitaetsklinikum Hamburg-Eppendorf | ? |
| Centro Nacional de Investigaciones Cardiovasculares Carlos III (F.S.P.) | 688 750 € |
| Norinnova AS | 0,00 € |
| Universitat de Barcelona | 599 250 € |
| Universitetet I Tromsoe - Norges Arktiske Universitet | 1 911 918 € |
| University of Southampton | 798 879 € |
https://cordis.europa.eu/project/id/101258941
Cette annonce se réfère à une date antérieure et ne reflète pas nécessairement l’état actuel. L’état actuel est présenté à la page suivante : Universitaetsklinikum Hamburg-Eppendorf, Hambourg, Allemagne.